The Venture Investing Strategy for Tough Times

I had an interesting conversation yesterday with a good buddy of mine who works at a top venture capital firm. I mentioned that Locust Walk Partners is considering doing company formation work. I wanted to know if he thought that we were crazy. He responded that he...

Is Licensing the new M&A?

For the past decade, the number of venture backed companies purchased by big pharma has not changed materially. There are only so many big companies and only so many deals that each company can do. With the renewal of consolidation between large companies...

Current market conditions

As part of LWP’s value add to the life science community, we are going to conduct a survey of big pharma/biotech BD, venture backed biotech CEO/CBO/VP BD, publicly traded biotech CEO/CBO/VP BD, and life science VCs about their thoughts on the state of the...

Commentary on Surviving the Biotech Crisis

Apologies for the significant delay in getting going with the blog. On Wednesday there was an interesting piece in the FierceBiotech (see below). Five tips for surviving the biotech crisis (full article) The going has been tough for small companies as of late....

Launch of Locust Walk Partners

I apologize to my loyal readership of 5 people that I haven’t posted in a while. Since August, Jay Mohr and I have been working on getting ready for and launching Locust Walk Partners. We both saw a major need in the marketplace for life science companies to...